Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PTC THERAPEUTICS, INC. Director's Dealing 2013

Jun 19, 2013

31046_dirs_2013-06-19_16a4744d-4477-44ff-82fe-737f6efe0887.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2013-06-19

Reporting Person: CREDIT SUISSE AG/ (10% Owner)

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Series Four Senior Preferred Stock $ Common Stock (276853) Indirect
Series Five Junior Preferred Stock $ Common Stock (1980029) Indirect

Footnotes

F1: See Footnote 1 in Exhibit 99.1.

F2: See Footnote 1 in Exhibit 99.1.

F3: See Footnote 1 in Exhibit 99.1.

F4: See Footnote 1 in Exhibit 99.1.

F5: See Footnote 1 in Exhibit 99.1.